Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

News Daily News

Reduced EF Evident in Some Elite Endurance Athletes

Michael O'Riordan

December 21, 2023

News Daily News

Don’t Avoid Statins in Elderly, Frail Patients: Two Retrospective Studies Argue

Yael L. Maxwell

December 15, 2023

News Daily News

Statin Use Has Plateaued in US Primary Prevention Patients

Michael O'Riordan

December 05, 2023

News Daily News

‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults

Michael O'Riordan

November 21, 2023

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Conference News AHA 2023

MINT Hints at Benefits of Liberal Transfusions in Acute MI With Anemia

L.A. McKeown

November 11, 2023

News Daily News

FDA Approves Paradise Renal Denervation System: What Comes Next?

Todd Neale

November 08, 2023

News Conference News VIVA 2023

‘Dire’ Lack of Vascular Care in Underserved Areas Needs Creativity, Compassion

L.A. McKeown

November 03, 2023

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

News Opinion Editor's Corner

What’s Going to Be Hot at TCT 2023

Shelley Wood

October 19, 2023

News Daily News

AHA, AMA Make Call for Enhanced Efforts to Control Americans’ BP

Todd Neale

September 07, 2023

News Daily News

ReCor’s Renal Denervation System Gets Thumbs Up From FDA Advisory Panel

L.A. McKeown

August 22, 2023

News Daily News

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

L.A. McKeown

July 11, 2023

News Conference News ADA 2023

Big Reductions in ASCVD Events With Bempedoic Acid in Primary Prevention

Michael O'Riordan

June 28, 2023

News Conference News SCAI 2023

Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI

L.A. McKeown

May 24, 2023

News Daily News

BASIL-2 Supports Endo-First Strategy for CLTI With Infrapopliteal Disease

L.A. McKeown

May 01, 2023

Advertisement

Top Endovascular News of 2023

Reduced EF Evident in Some Elite Endurance Athletes

Don’t Avoid Statins in Elderly, Frail Patients: Two Retrospective Studies Argue

Statin Use Has Plateaued in US Primary Prevention Patients

‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

MINT Hints at Benefits of Liberal Transfusions in Acute MI With Anemia

FDA Approves Paradise Renal Denervation System: What Comes Next?

‘Dire’ Lack of Vascular Care in Underserved Areas Needs Creativity, Compassion

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

What’s Going to Be Hot at TCT 2023

AHA, AMA Make Call for Enhanced Efforts to Control Americans’ BP

ReCor’s Renal Denervation System Gets Thumbs Up From FDA Advisory Panel

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

Big Reductions in ASCVD Events With Bempedoic Acid in Primary Prevention

Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI

BASIL-2 Supports Endo-First Strategy for CLTI With Infrapopliteal Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content